Related Experiment Video

Updated: May 3, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

1.1K

[Recent advances in the research on mechanisms underlying podocyte-specific gene mutation-related steroid-resistant

Li-Wen Zhang1, Le-Ping Wang

  • 1Department of Pediatrics, Changzhou Traditional Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine, Changzhou, Jiangsu 213003, China. zyywlp@126.com.

Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics
|January 28, 2014
PubMed

Insights

Steroid-resistant nephrotic syndrome is often caused by podocyte gene mutations. This review details key mutated genes and their impact on the disease.

Area of Science:

  • Nephrology
  • Genetics
  • Molecular Biology

Background:

  • Steroid-resistant nephrotic syndrome (SRNS) presents a major clinical challenge with incompletely understood pathogenesis.
  • Podocyte injury is increasingly recognized as a critical factor in SRNS development.
  • Genetic factors, specifically mutations in podocyte-expressed genes, are implicated in a significant subset of SRNS cases.

Purpose of the Study:

  • To review and characterize key podocyte-specific genes associated with SRNS.
  • To explore the role of these genetic mutations in the pathogenesis of SRNS.
  • To discuss the implications of these mutations for diagnosis, treatment, and prognosis of SRNS.

Main Methods:

  • Literature review of studies identifying podocyte gene mutations in SRNS.
  • Analysis of identified genes including NPHS2, NPHS1, WT1, TRPC6, MDR1, PLCE1, LMX1B, and LAMB2.
  • Synthesis of information regarding the function and mutation impact of these genes.

Main Results:

  • Identification of several critical podocyte genes (NPHS2, NPHS1, WT1, TRPC6, MDR1, PLCE1, LMX1B, LAMB2) frequently mutated in SRNS.
  • Characterization of the specific functions of these genes within podocytes.
  • Evidence linking mutations in these genes to the development and progression of SRNS.

Conclusions:

  • Podocyte gene mutations are a significant cause of steroid-resistant nephrotic syndrome.
  • Understanding these genetic underpinnings is crucial for improving SRNS diagnosis and management.
  • Further research into these genes may reveal novel therapeutic targets for SRNS.

More Related Videos

Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli12:19

Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli

Published on: June 27, 2015

10.6K
Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

7.9K

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1.2K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
409
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
549
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121